RELATED STUDY

Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review.

Key Findings:  Cannabis may be useful for symptom relief in Crohn's disease such as pain, nausea, and loss of appetite. However, studies with high methodological quality, sufficient sample size, and study duration are mandatory to determine potential therapeutic effects and risks of cannabis in gastroenterology. Currently, use of tetrahydrocannabinol to alleviate symptoms such as pain and appetite loss in Crohn's disease should only be considered in individual patients after failure of established medical therapies and only after careful risk-benefit assessment.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Germany

Year of Pub:  2016


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Not Applicable